Cart (0 Items)
Your cart is currently empty.
View Products
              
              
              
              | Size | 100ug, 1MG  | 
		
|---|---|
| Isotype | IgG2-G4-kappa  | 
		
| Brand | ProteoGenix  | 
		
| Product type | Primary Antibodies  | 
		
| Clonality | Monoclonal Antibody  | 
		
| Expression system | Mammalian cells  | 
		
| Applications | Elisa, WB  | 
		
| Product name | Ravulizumab Biosimilar - Anti-C5 mAb - Research Grade | 
|---|---|
| Source | CAS 1803171-55-2 | 
| Species | Humanized | 
| Purity | >85% | 
| Buffer | PBS buffer PH7.5 | 
| Delivery condition | Blue ice (+4°C) | 
| Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed | 
| Storage condition | store at -80°C | 
| Brand | ProteoGenix | 
| Aliases /Synonyms | Ravulizumab,ALXN-1210,ravulizumab-cwvz,C5,anti-C5 | 
| Reference | PX-TA1452 | 
| Note | For research use only. Not suitable for clinical or therapeutic use. | 
| Isotype | IgG2-G4-kappa | 
| Clonality | Monoclonal Antibody | 
                Immobilized Human C5 recombinant protein (cat. No. PX-P5117) at 0.5µg/mL (100µL/well) can bind Ravulizumab Biosimilar - Anti-C5 mAb (cat. No. PX-TA1452) in indirect ELISA with Goat Anti-Human IgG secondary antibody coupled with HRP measured by OD450 giving an EC50 at 525.8M.
Related products
Send us a message from the form below
Reviews
There are no reviews yet.